Morgan Stanley Named Cognizant (CTSH) a Long Research Tactical Idea
Tweet
Share
E-mailGet Alerts CTSH Hot Sheet
Price: $61.70 +1.26%
Rating Summary:
19 Buy, 21 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
19 Buy, 21 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Morgan Stanley named Cognizant Technology (Nasdaq: CTSH) a Long Research Tactical Idea.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cognizant and Benchling to deploy R&D platform at Kyowa Kirin labs
- Morgan Stanley Upgrades Merck (MRK) to Overweight
- Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
